Epigenetic regulation of MED12: a key contributor to the leukemic chromatin landscape and transcriptional dysregulation
Abstract Background MED12 is a key regulator of transcription and chromatin architecture, essential for normal hematopoiesis. While its dysregulation has been implicated in hematological malignancies, the mechanisms driving its upregulation in acute myeloid leukemia (AML) remain poorly understood. W...
Saved in:
| Main Authors: | Arundhati Chavan, Cassidy Jones, Whit Lawrence, Samrat Roy Choudhury |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Epigenetics & Chromatin |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13072-025-00610-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MED12 mutation induces RTK inhibitor resistance in NSCLC via MEK/ERK pathway activation by inflammatory cytokines
by: Hyun-Min Ryu, et al.
Published: (2025-08-01) -
Treatment results of pediatric acute myeloid leukemia with epigenetic drugs addition
by: V. S. Nemirovchenko, et al.
Published: (2020-07-01) -
Iron overload promotes myeloid differentiation of normal hematopoietic stem cells and educates macrophage mediated immunosuppression in acute myeloid leukemia
by: Feifei Yang, et al.
Published: (2025-08-01) -
MED8 is related to tumor immunity and has predictive value in the prognosis and treatment of glioma
by: Jingyi Yang, et al.
Published: (2025-07-01) -
Scenarios as collaborative tool empowering the policymaking process. The case of MedTech sector in Europe
by: Artur Ochojski, et al.
Published: (2022-11-01)